Welcome to Lianhe Aigen Pharma Co, Ltd, a leading provider of ADC CDMO services dedicated to advancing the field of targeted therapeutics. We specialize in the development and manufacturing of antibody-drug conjugates (ADCs) and use our extensive expertise to support pharmaceutical and biotech companies in their search for innovative cancer treatments. Our comprehensive ADC CDMO services span every stage of the product lifecycle, including:

1. **Process Development:** We provide customized solutions for the development and optimization of ADC manufacturing processes that ensure high yield and purity.

2. **Analytical development:** Our state-of-the-art analytical capabilities allow us to perform rigorous characterization and quality control of ADCs, ensuring compliance with regulatory standards.

3. **Clinical manufacturing:** With robust facilities and scalable production capabilities, we offer cGMP-compliant manufacturing of ADCs for clinical trials, from early-stage to large-scale production.

4. **Formulation Development:** Our dedicated team develops optimized formulations for the delivery of ADCs that improve stability and therapeutic efficacy.

5. **Regulatory Support:** We guide our clients through the complex regulatory landscape, providing experienced support with IND filings, CMC documentation and interactions with regulatory authorities.

We pride ourselves on our collaborative approach, working closely with our clients to understand their individual needs and provide solutions that promote their success in the marketplace. With a strong focus on innovation, quality and schedule management, we are your trusted partner for ADC CDMO services. Discover how we can help you bring your ADC products to life and make a significant contribution to the fight against cancer. Contact us today to learn more about our services and how we can help you achieve your goals.